SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-17-006502
Filing Date
2017-04-13
Accepted
2017-04-13 16:05:56
Documents
5
Period of Report
2017-06-01
Effectiveness Date
2017-04-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A omed-def14a_20170601.htm DEF 14A 949526
2 GRAPHIC g201704131658405532049.jpg GRAPHIC 54392
3 GRAPHIC g201704131658405132047.jpg GRAPHIC 4390
4 GRAPHIC g201704131658347382046.jpg GRAPHIC 4390
5 GRAPHIC g201704131658405242048.jpg GRAPHIC 80399
  Complete submission text file 0001564590-17-006502.txt   1148893
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35993 | Film No.: 17760701
SIC: 2834 Pharmaceutical Preparations